DocDollars

Eli Lilly and Company

IN · United States · Reporting entity ID 100000000088

Total reported 2019–2025
$3.62B
#3 of 2,960 reporting companies — 4.4% of all reported industry payments
$45.0M in general payments across 36,564 records, plus $3.58B in research funding across 80,449 records.

How it breaks down

General payments $45,011,092
Research funding $3,575,872,229

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Eli Lilly and Company reported $3.62B to US doctors and teaching hospitals from 2019 to 2025, ranking #3 of 2,960 reporting companies. 99% of that was research funding and 1% general payments such as consulting, speaking, food and travel. 36,564 general payment records and 80,449 research records were filed.

Common questions about Eli Lilly and Company

How much has Eli Lilly and Company paid US doctors?

Eli Lilly and Company reported $3,620,883,321 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $45,011,092 in general payments, $3,575,872,229 in research funding.

How does Eli Lilly and Company rank among drug and device companies?

It ranks #3 of 2,960 reporting entities by total reported value, about 4.4% of all industry payments in the dataset.

Does a payment from Eli Lilly and Company mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.